Bachem Americas
United States Updated 9 July 2026
Bachem Americas is an API manufacturer based in United States. It holds 7 active US drug master files and 4 valid CEPs across a filed portfolio of 8 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 28 June 2024 as VAI.
2
registered plants
2 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 28 June 2024 VAI US FDA
- 27 March 2023 VAI US FDA
- 13 December 2019 VAI US FDA
- 12 June 2019 VAI US FDA
- 5 February 2019 NAI US FDA
- 18 May 2018 VAI US FDA
- 25 February 2016 VAI US FDA
- 7 November 2014 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Vista, United States | 3000718309 |
| Torrance, United States | 2024023 |
What they file, and where
| Molecule | Regulators | Docs |
| Desmopressin | EDQM, US FDA | 3 |
| Calcitonin (Salmon) | EDQM | 2 |
| Exenatide | US FDA | 1 |
| Lanreotide | US FDA | 1 |
| Liraglutide | US FDA | 1 |
| Parathyroid Hormone | US FDA | 1 |
| Salmon Calcitonin | US FDA | 1 |
| Vasopressin | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Bachem Americas comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 28 June 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates